The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.
Accredited to ISO/IEC 17043
Lyophilised for enhanced stability
100% human serum
Monthly reporting
Submit results and view reports online via RIQAS.Net
Register up to five instruments at no extra cost
Suitable for first and second trimester screening
Parameters
AFP, hCG (free beta), hCG (total), Inhibin A, PAPP-A, and Unconjugated Oestriol"